They found that SUVmax could effectively differentiate WHO/ISUP grade (3-4 vs. 1-2) and adverse pathology (positive vs. negative) (both P < 0.001), however, with no difference in CT value, suggesting that PSMA PET/CT molecular imaging can reflect the pathological features of ccRCC. The gene discussed is FOLH1; the disease is nonpapillary renal cell carcinoma.